...
首页> 外文期刊>PLoS One >β-glucan administration improves growth performance and gut health in New Zealand White and APRI rabbits with different breed responses
【24h】

β-glucan administration improves growth performance and gut health in New Zealand White and APRI rabbits with different breed responses

机译:β-葡聚糖管理在新西兰白色和APRI兔子中提高了生长性能和肠道健康,具有不同的品种反应

获取原文

摘要

This study investigated the effects of oral administration of β-glucan 1,3 (pharmaceutical grade 10%) on growth performance and carcass traits in two breeds of weanling rabbits adapted to survive in Egypt, New Zealand White (NZW) and Animal Production Research Institute (APRI) rabbits, with special attention to relative mRNA expression of interleukins and antioxidant enzyme genes, biochemical, and histological alterations. Oral administration of β-glucan with doses 0.25 and 0.5 ml per one-liter of drinking water significantly accelerated body weight gain (BWG) in both rabbits’ breeds, reduced total feed consumption (FC), and reduced feed conversion ratio (FCR), especially the 0.5 ml per one-liter dose in both rabbit breeds. There are remarkable differences in all the growth performance traits due to breed effect. The interaction effect between β-glucan and breed significantly improved BWG, FC, and FCR. There were non-significant differences in all carcass traits studied due to oral administration of β-glucan with both doses, except in dressing percentages. The highest of the dressing percentages were observed at doses 0.25 ml per one-liter (51%) and 0.5 ml per one-liter (52%) compared with control (50%). Our findings show significant variations in the final BW, total daily gain, feed consumption, and total feed conversion ratio between NZW and APRI rabbits. Absence of significant differences in the hot carcass weight and dressing percentage between the genetic groups had been reported in this study. Supplementing NZW and APRI rabbits with β-glucan increased blood total protein and globulin. The duodenal villi dimensions, splenic lymphoid diameter, muscular fiber diameter, and muscular glycogen areas were significantly increased by β-glucan administration. Expression of intestinal interleukin-18 ( IL-18 ) in NZW rabbits treated with 0.25 and 0.5 doses of β-glucan was significantly upregulated and enhanced the immune response. β-glucan upregulated the expression of intestinal occludin mRNA particularly at dose 0.5 β-glucan as well as upregulated intestinal superoxide dismutase 1 ( SOD1 ) and glutathione peroxidase 1 ( GPx1 ), which modulates anti-inflammatory and antioxidant properties. In conclusion, oral administration of β-glucan at a dose of 0.25 or 0.5 ml per one-liter drinking water provided beneficial effects in the growth performance and health status of rabbits.
机译:本研究调查了口服β-葡聚糖1,3(药物级10%)对两种伴侣的生长性能和胴体性状的影响,适用于埃及生存,新西兰白人(NZW)和动物生产研究所(APRI)兔,特别注意白细胞介素和抗氧化酶基因的相对mRNA表达,生化和组织学改变。口服β-葡聚糖剂量为0.25和0.5ml,每升饮用水,兔品种的体重增加(BWG)显着加速,减少总供给消耗(FC),降低饲料转化率(FCR),特别是兔品种中每升剂量0.5毫升。由于品种效应,所有增长性能特征都存在显着差异。 β-葡聚糖和品种之间的相互作用效应显着改善BWG,Fc和FCR。除了敷料百分比外,由于口服β-葡聚糖的口服施用,β-葡聚糖的所有胴体特征存在非显着差异。与对照(50%)相比,每升0.25ml(51%)和0.5mL每升(51%)和0.5mL的剂量0.25ml(52%)观察到最高的敷料百分比。我们的发现显示了NZW和APRI兔子之间的最终BW,总日益增长,饲料消耗和总饲料转换率的显着变化。在本研究中报道了遗传基团之间的热胴体重量和敷料百分比的显着差异。用β-葡聚糖增加NZW和APRI兔子,增加血液总蛋白和球蛋白。 β-葡聚糖给药显着增加了十二指肠绒毛尺寸,脾淋巴淋巴曲线,肌肉纤维直径和肌肉糖原区域。用0.25和0.5剂β-葡聚糖治疗的NZW兔中的肠道白细胞介素-18(IL-18)的表达显着上调并提高了免疫应答。 β-葡聚糖上调特别是在剂量0.5β-葡聚糖以及上调肠超氧化物歧化酶1(SOD1)和谷胱甘肽过氧化物酶1(GPX1)中的表达,其调节抗炎和抗氧化性能。总之,每升饮水剂量为0.25或0.5毫升时口服β-葡聚糖为兔的生长绩效和健康状况提供有益效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号